New Hope for Heart Disease Patients in the UK

A new drug called Amvuttra is making waves in the UK. It's designed to help people with a rare heart condition called ATTR-CM. This condition happens when faulty proteins build up in the heart, which can make it hard for the heart to work properly. The drug is already approved for this use, as well as for nerve damage caused by the same condition. The UK's health watchdog is expected to give the final go-ahead next month. This will mean that more people who need it can get the drug through the NHS. Right now, there are about 1, 500 people in the UK who could benefit from this treatment. Amvuttra is also doing well in other parts of the world. In the last three months of the year, it made over $685 million in sales. That's a lot more than it made the year before. The drug is already approved in the US and Japan, which are big markets for this kind of treatment. But why is this drug so important? Well, ATTR-CM is a serious condition. It can be hard to treat, and many people don't have good options. Amvuttra offers a new way to help these patients. It's a big deal for people who have been waiting for a treatment that can make a real difference. The drug is given by injection, and it works by stopping the faulty proteins from building up in the heart. This can help the heart work better and improve the quality of life for people with ATTR-CM. It's a promising development in the fight against this rare but serious condition.